DC Biosciences Ltd. provides pharmaceutical and biotech companies with cutting edge proteomics services to accelerate the development of safer drugs. We are best placed to apply our knowledge and experience in a wide range of bioscience disciplines including quantitative proteomics and bioinformatics to provide solutions in key areas of drug discovery and development.

We have developed a quantitative proteomics-based technology portfolio that offers solutions to preclinical activities of the drug discovery process and developed new processes for biomarker discovery and validation, drug re-profiling and repositioning..